Skip to main content
MEDICLINIC INTERNATIONAL PLC logo

MEDICLINIC INTERNATIONAL PLC — Investor Relations & Filings

Ticker · MDC ISIN · US58471Q1004 LEI · 2138002S5BSBIZTD5I60 IL Human health and social work activities
Open in API
Filings indexed 648 across all filing types
Latest filing 2025-10-02 Major Shareholding Noti…
Country GB United Kingdom
Listing IL MDC

About MEDICLINIC INTERNATIONAL PLC

https://www.mediclinic.com/en/home.html

Mediclinic International PLC is a diversified international private healthcare services group focused on providing specialist-orientated, multi-disciplinary services across the continuum of care. The company's clinical offerings include acute care, outpatient consultations, pre-hospital emergency services, day case surgery, and inpatient care. With a core purpose to enhance the quality of life, the group emphasizes delivering high-quality, patient-centric healthcare. Mediclinic operates with a sustainable, long-term approach, upholding high standards of clinical governance and investing in skilled professionals, advanced facilities, and modern medical equipment to be a trusted provider for clients, medical practitioners, and funders.

Recent filings

Filing Released Lang Actions
Form 8.3 - SPIRE HEALTHCARE GROUP PLC
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more during an M&A transaction. While it relates to M&A activity, it is specifically a disclosure of shareholding positions rather than a merger announcement or takeover bid document itself. Given the specific nature of these disclosures regarding major shareholdings in the context of a takeover, it fits best as a Major Shareholding Notification (MRQ).
2025-10-02 English
[accounts-with-accounts-type-audit-exemption-subsiduary] made_up_date=2025-03-31
Regulatory Filings
2025-08-05 English
Consolidated accounts of parent company for subsidiary company period ending 31/03/25
Regulatory Filings
2025-06-26 English
Full accounts made up to 2024-03-31
Regulatory Filings
2024-07-26 English
Group of companies' accounts made up to 2023-03-31
Regulatory Filings
2023-10-03 English
De-listing and cancellation of trading of shares
Delisting Announcement Classification · 100% confidence The document is an RNS announcement (indicated by 'RNS Number : 0349B') detailing the final steps of a recommended cash acquisition (takeover) of Mediclinic International plc by Manta Bidco Limited. The core subject is the '# DE-LISTING AND CANCELLATION OF TRADING OF MEDICLINIC SHARES' following the Scheme becoming Effective. This announcement is about the consequence of a takeover, specifically the delisting of shares from the London Stock Exchange, JSE, and NSX. This event is directly related to a major corporate transaction involving a change in control/ownership structure, which falls under the scope of M&A Activity (TAR). However, the primary, immediate action announced is the delisting itself. Since 'Delisting Announcement' (DLST) is a specific category for the official notice that stock will be removed from an exchange, and this document explicitly announces the cancellation of listing and trading, DLST is the most precise fit for the content of this specific filing, even though it is a consequence of a takeover (TAR). Given the explicit focus on delisting, DLST is chosen over TAR.
2023-05-30 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.